Blood Component Utilization Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Plasma, Red Blood Cells, Platelets); Application (Body Contouring, Skin Rejuvenation and Resurfacing, Others)

Report Code: TIPRE00018768 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Blood transfusion is an integral part of patient management. Indications for blood use must be evident in ordering clinicians to avoid its misuse and prevent unnecessary exposure of the patient to donor blood antigens, adverse reactions, and transmissible transfusion diseases.

MARKET DYNAMICS

The blood component utilization market is driving due to the rise in incidence in trauma cases, rising prevalence of target diseases. However, minimally invasive technology, which no longer needs a blood transfusion, hinders the market's growth. Moreover, advancements in blood transfusion instruments are expected to provide opportunities in the global blood component utilization market.

MARKET SCOPE

The "Blood Component Utilization Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood component utilization market with detailed market segmentation by product type and application. The blood component utilization market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in blood component utilization market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The blood component utilization market is segmented on the basis of product type and application. Based on product type, the market is segmented as plasma, red blood cells, platelets. Based on application, the market is segmented as body contouring, skin rejuvenation and resurfacing, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Blood component utilization market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood component utilization market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting blood component utilization market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood component utilization market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the blood component utilization market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Blood component utilization market are anticipated to have lucrative growth opportunities in the future with the rising demand for Blood component utilization in the global market. Below mentioned is the list of few companies engaged in the Blood component utilization market.

The report also includes the profiles of key players in blood component utilization market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- UCLA Medical Center
- Johns Hopkins Hospital
- Massachusetts General Hospital
- Mayo Clinic
- Cleveland Clinic
- Brigham and Women's Hospital
- New York-Presbyterian Hospital
- University of Michigan Hospitals and Health Centers
- Indiana University Health
- UCSF Medical Center
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Component Utilization Market - By Product Type
1.3.2 Blood Component Utilization Market - By Application
1.3.3 Blood Component Utilization Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD COMPONENT UTILIZATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD COMPONENT UTILIZATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD COMPONENT UTILIZATION MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD COMPONENT UTILIZATION - GLOBAL MARKET OVERVIEW
6.2. BLOOD COMPONENT UTILIZATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BLOOD COMPONENT UTILIZATION MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PLASMA
7.3.1. Overview
7.3.2. Plasma Market Forecast and Analysis
7.4. RED BLOOD CELLS
7.4.1. Overview
7.4.2. Red Blood Cells Market Forecast and Analysis
7.5. PLATELETS
7.5.1. Overview
7.5.2. Platelets Market Forecast and Analysis
8. BLOOD COMPONENT UTILIZATION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BODY CONTOURING
8.3.1. Overview
8.3.2. Body Contouring Market Forecast and Analysis
8.4. SKIN REJUVENATION AND RESURFACING
8.4.1. Overview
8.4.2. Skin Rejuvenation and Resurfacing Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. BLOOD COMPONENT UTILIZATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Blood Component Utilization Market Overview
9.1.2 North America Blood Component Utilization Market Forecasts and Analysis
9.1.3 North America Blood Component Utilization Market Forecasts and Analysis - By Product Type
9.1.4 North America Blood Component Utilization Market Forecasts and Analysis - By Application
9.1.5 North America Blood Component Utilization Market Forecasts and Analysis - By Countries
9.1.5.1 United States Blood Component Utilization Market
9.1.5.1.1 United States Blood Component Utilization Market by Product Type
9.1.5.1.2 United States Blood Component Utilization Market by Application
9.1.5.2 Canada Blood Component Utilization Market
9.1.5.2.1 Canada Blood Component Utilization Market by Product Type
9.1.5.2.2 Canada Blood Component Utilization Market by Application
9.1.5.3 Mexico Blood Component Utilization Market
9.1.5.3.1 Mexico Blood Component Utilization Market by Product Type
9.1.5.3.2 Mexico Blood Component Utilization Market by Application
9.2. EUROPE
9.2.1 Europe Blood Component Utilization Market Overview
9.2.2 Europe Blood Component Utilization Market Forecasts and Analysis
9.2.3 Europe Blood Component Utilization Market Forecasts and Analysis - By Product Type
9.2.4 Europe Blood Component Utilization Market Forecasts and Analysis - By Application
9.2.5 Europe Blood Component Utilization Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Blood Component Utilization Market
9.2.5.1.1 Germany Blood Component Utilization Market by Product Type
9.2.5.1.2 Germany Blood Component Utilization Market by Application
9.2.5.2 France Blood Component Utilization Market
9.2.5.2.1 France Blood Component Utilization Market by Product Type
9.2.5.2.2 France Blood Component Utilization Market by Application
9.2.5.3 Italy Blood Component Utilization Market
9.2.5.3.1 Italy Blood Component Utilization Market by Product Type
9.2.5.3.2 Italy Blood Component Utilization Market by Application
9.2.5.4 Spain Blood Component Utilization Market
9.2.5.4.1 Spain Blood Component Utilization Market by Product Type
9.2.5.4.2 Spain Blood Component Utilization Market by Application
9.2.5.5 United Kingdom Blood Component Utilization Market
9.2.5.5.1 United Kingdom Blood Component Utilization Market by Product Type
9.2.5.5.2 United Kingdom Blood Component Utilization Market by Application
9.2.5.6 Rest of Europe Blood Component Utilization Market
9.2.5.6.1 Rest of Europe Blood Component Utilization Market by Product Type
9.2.5.6.2 Rest of Europe Blood Component Utilization Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Blood Component Utilization Market Overview
9.3.2 Asia-Pacific Blood Component Utilization Market Forecasts and Analysis
9.3.3 Asia-Pacific Blood Component Utilization Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Blood Component Utilization Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Blood Component Utilization Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Blood Component Utilization Market
9.3.5.1.1 Australia Blood Component Utilization Market by Product Type
9.3.5.1.2 Australia Blood Component Utilization Market by Application
9.3.5.2 China Blood Component Utilization Market
9.3.5.2.1 China Blood Component Utilization Market by Product Type
9.3.5.2.2 China Blood Component Utilization Market by Application
9.3.5.3 India Blood Component Utilization Market
9.3.5.3.1 India Blood Component Utilization Market by Product Type
9.3.5.3.2 India Blood Component Utilization Market by Application
9.3.5.4 Japan Blood Component Utilization Market
9.3.5.4.1 Japan Blood Component Utilization Market by Product Type
9.3.5.4.2 Japan Blood Component Utilization Market by Application
9.3.5.5 South Korea Blood Component Utilization Market
9.3.5.5.1 South Korea Blood Component Utilization Market by Product Type
9.3.5.5.2 South Korea Blood Component Utilization Market by Application
9.3.5.6 Rest of Asia-Pacific Blood Component Utilization Market
9.3.5.6.1 Rest of Asia-Pacific Blood Component Utilization Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Blood Component Utilization Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Blood Component Utilization Market Overview
9.4.2 Middle East and Africa Blood Component Utilization Market Forecasts and Analysis
9.4.3 Middle East and Africa Blood Component Utilization Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Blood Component Utilization Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Blood Component Utilization Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Blood Component Utilization Market
9.4.5.1.1 South Africa Blood Component Utilization Market by Product Type
9.4.5.1.2 South Africa Blood Component Utilization Market by Application
9.4.5.2 Saudi Arabia Blood Component Utilization Market
9.4.5.2.1 Saudi Arabia Blood Component Utilization Market by Product Type
9.4.5.2.2 Saudi Arabia Blood Component Utilization Market by Application
9.4.5.3 U.A.E Blood Component Utilization Market
9.4.5.3.1 U.A.E Blood Component Utilization Market by Product Type
9.4.5.3.2 U.A.E Blood Component Utilization Market by Application
9.4.5.4 Rest of Middle East and Africa Blood Component Utilization Market
9.4.5.4.1 Rest of Middle East and Africa Blood Component Utilization Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Blood Component Utilization Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Blood Component Utilization Market Overview
9.5.2 South and Central America Blood Component Utilization Market Forecasts and Analysis
9.5.3 South and Central America Blood Component Utilization Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Blood Component Utilization Market Forecasts and Analysis - By Application
9.5.5 South and Central America Blood Component Utilization Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Blood Component Utilization Market
9.5.5.1.1 Brazil Blood Component Utilization Market by Product Type
9.5.5.1.2 Brazil Blood Component Utilization Market by Application
9.5.5.2 Argentina Blood Component Utilization Market
9.5.5.2.1 Argentina Blood Component Utilization Market by Product Type
9.5.5.2.2 Argentina Blood Component Utilization Market by Application
9.5.5.3 Rest of South and Central America Blood Component Utilization Market
9.5.5.3.1 Rest of South and Central America Blood Component Utilization Market by Product Type
9.5.5.3.2 Rest of South and Central America Blood Component Utilization Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BLOOD COMPONENT UTILIZATION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD COMPONENT UTILIZATION MARKET, KEY COMPANY PROFILES
12.1. UCLA MEDICAL CENTER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNS HOPKINS HOSPITAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MASSACHUSETTS GENERAL HOSPITAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MAYO CLINIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CLEVELAND CLINIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRIGHAM AND WOMEN'S HOSPITAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NEW YORK-PRESBYTERIAN HOSPITAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INDIANA UNIVERSITY HEALTH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. UCSF MEDICAL CENTER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. UCLA Medical Center
2. Johns Hopkins Hospital
3. Massachusetts General Hospital
4. Mayo Clinic
5. Cleveland Clinic
6. Brigham and Women's Hospital
7. New York-Presbyterian Hospital
8. University of Michigan Hospitals and Health Centers
9. Indiana University Health
10. UCSF Medical Center
TIPRE00018768
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking